MedPath

Cleansing Device for the Treatment of Scalp and Hair Conditions

Not Applicable
Recruiting
Conditions
Dandruff
Hair Loss
Seborrheic Dermatitis
Interventions
Device: Off-brand Waterpik®
Registration Number
NCT05319444
Lead Sponsor
University of Minnesota
Brief Summary

The objective of this study is to evaluate an improvement of scalp health after the use of an investigational off-label WaterPik and brush device aimed to massage and cleanse the scalp.

Detailed Description

Seborrheic dermatitis and dandruff are skin conditions that present with common features and respond similarly to treatments. Dandruff involves flaking skin that can cause irritation and itching. Dandruff only involves the scalp, whereas seborrheic dermatitis can occur on the scalp, face, chest, and retro-auricular areas. Seborrheic dermatitis can also result in itching and flaking, as well as inflammation and erythema. Both dandruff and seborrheic dermatitis are known to be harmful to the scalp.

Despite shampoo and washing, one may still continue to have flaking and scale present on the scalp. There are numerous scalp massages and brushes on the consumer market. Waterpik® was FDA approved in 2018 to provide pressured water combined with a powered toothbrush for optimal plaque and particle removal when cleaning the mouth and teeth. Waterpik® now has several products on the market designed for oral health, pet care, and washing in the shower. The off-label design utilizes the Waterpik® device, but with adjustments optimized for scalp health.

Through the investigational use of the off-label WaterPik® and brush device, the investigators propose the technique of massage and gentle water pressure will reduce seborrheic dermatitis and dandruff on the scalp.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Participants must qualify for one of the following scalp conditions based on clinical opinion of a board-certified dermatologist: healthy scalp, dandruff, seborrheic dermatitis, or hair loss disease

  • All Women of Child Bearing Potential must indicate use of two of the following contraceptive methods. The WaterPik device uses an ultrasonic technology which includes ultrasound. Unnecessary ultrasound is not recommended for pregnant women.

    • Combined (estrogen and progestogen containing) hormonal contraception associated with inhibition of ovulation (oral, intravaginal, or transdermal)
    • Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, or implantable)
    • Intrauterine device (IUD)
    • Intraurerine hormone-releasing system (IUS)
    • Vasectomized partner
    • Sexual abstinence
    • Barrier method, such as a condom
Exclusion Criteria
  • Non-English speaking
  • Exclusion related to pregnancy, lactation, or plans to become pregnant over the course of the study (based on self-report from the participant)
  • Current clinical condition that, in the opinion of the site investigator, would interfere with adherence to study requirements

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Healthy Scalp and one treatmentOff-brand Waterpik®Participants with healthy scalps who will receive one treatment with the device and complete one in-person follow-up.
Seborrheic Dermatitis and three treatmentsOff-brand Waterpik®Participants with seborrheic dermatitis who will receive three treatments with the device and complete one in-person follow-up.
Dandruff and one treatmentOff-brand Waterpik®Participants with dandruff who will receive one treatment with the device and complete one in-person follow-up.
Healthy Scalp and three treatmentsOff-brand Waterpik®Participants with healthy scalps who will receive three treatments with the device and complete one in-person follow-up.
Dandruff and three treatmentsOff-brand Waterpik®Participants with dandruff who will receive three treatments with the device and complete one in-person follow-up.
Hair loss disease and one treatmentOff-brand Waterpik®Participants with hair loss disease who will receive one treatment with the device and complete one in-person follow-up.
Seborrheic Dermatitis with one treatmentOff-brand Waterpik®Participants with seborrheic dermatitis disease who will receive one treatment with the device and complete one in-person follow-up.
Hair loss disease and three treatmentsOff-brand Waterpik®Participants with hair loss disease who will receive three treatments with the device and complete one in-person follow-up.
Primary Outcome Measures
NameTimeMethod
Change in Adherent Scalp Flaking Scale (ASFS)4 weeks

The presence of dandruff flakes adhereing to the scalp in 8 defined areas is rated on a scale of 0-10 per area, where 0 indicates no flakes and 10 indicates heavy flaking. This is combined for total scores ranging from 0-80.

Secondary Outcome Measures
NameTimeMethod
Change in Patient Sensory Assessment of Scalp & Hair Score4 weeks

This Score is based on 12 descriptions that patients rate 0-10 to assess the condition of their scalp and hair. A higher score means a worse outcome.

Change in Erythema Score4 weeks

The presence of erythema is rated on a scale of 0-4, where 0 indicates None, 1 indicates Minimal - barely perceptible erythema, 2 indicates Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema, 3 indicates Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red), and 4 indicates Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema. The higher score means a worse outcome.

Trial Locations

Locations (1)

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath